Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 535

1.

Serum Albumin, Lipid and Drug Binding.

Nishi K, Yamasaki K, Otagiri M.

Subcell Biochem. 2020;94:383-397. doi: 10.1007/978-3-030-41769-7_15. Review.

PMID:
32189308
2.

S-Nitrosated alpha-1-acid glycoprotein exhibits antibacterial activity against multidrug-resistant bacteria strains and synergistically enhances the effect of antibiotics.

Ishima Y, Watanabe K, Chuang VTG, Takeda I, Kuroda T, Ogawa W, Watanabe H, Iwao Y, Ishida T, Otagiri M, Maruyama T.

FASEB Bioadv. 2019 Feb 4;1(3):137-150. doi: 10.1096/fba.1018. eCollection 2019 Mar.

3.

[Strategy of Drug Development Based on the Bioactive Gas-carrying Capacity of Hemoglobin].

Taguchi K, Matsumoto K, Maruyama T, Otagiri M.

Yakugaku Zasshi. 2020;140(2):141-146. doi: 10.1248/yakushi.19-00187-1. Japanese.

4.

Effects of arterial hemorrhage speed on the blood coagulation/fibrinolysis system and hemodynamics in rats.

Furukawa S, Sasao A, Yonemitsu K, Ohtsu Y, Tsutsumi H, Taguchi K, Otagiri M, Nishitani Y.

Blood Coagul Fibrinolysis. 2020 Jan 30. doi: 10.1097/MBC.0000000000000899. [Epub ahead of print]

PMID:
32004201
5.

Carbon Monoxide Rescues the Developmental Lethality of Experimental Rat Models of Rhabdomyolysis-Induced Acute Kidney Injury.

Taguchi K, Ogaki S, Nagasaki T, Yanagisawa H, Nishida K, Maeda H, Enoki Y, Matsumoto K, Sekijima H, Ooi K, Ishima Y, Watanabe H, Fukagawa M, Otagiri M, Maruyama T.

J Pharmacol Exp Ther. 2020 Mar;372(3):355-365. doi: 10.1124/jpet.119.262485. Epub 2020 Jan 10.

PMID:
31924689
6.

Repeated Administration of Kupffer Cells-Targeting Nanoantioxidant Ameliorates Liver Fibrosis in an Experimental Mouse Model.

Maeda H, Minayoshi Y, Ichimizu S, Mizuta Y, Nagasaki T, Matsusaka K, Oshiro S, Oniki K, Saruwatari J, Ishima Y, Watanabe H, Otagiri M, Maruyama T.

Biol Pharm Bull. 2020;43(1):93-101. doi: 10.1248/bpb.b19-00599.

7.

Processing grapefruit juice with γ-cyclodextrin attenuates its inhibitory effect on cytochrome P450 3A activity.

Yamasaki K, Iohara D, Oyama Y, Nishizaki N, Kawazu S, Nishi K, Kadowaki D, Taguchi K, Otagiri M, Seo H.

J Pharm Pharmacol. 2020 Mar;72(3):356-363. doi: 10.1111/jphp.13212. Epub 2019 Dec 11.

PMID:
31828807
8.

Albumin domain mutants with enhanced Aβ binding capacity identified by phage display analysis for application in various peripheral Aβ elimination approaches of Alzheimer's disease treatment.

Ishima Y, Mimono A, Tuan Giam Chuang V, Fukuda T, Kusumoto K, Okuhira K, Suwa Y, Watanabe H, Ishida T, Morioka H, Maruyama T, Otagiri M.

IUBMB Life. 2020 Apr;72(4):641-651. doi: 10.1002/iub.2203. Epub 2019 Dec 3.

PMID:
31794135
9.

Interaction of Aripiprazole With Human α1-Acid Glycoprotein.

Nishi K, Sakurama K, Kobashigawa Y, Morioka H, Udo N, Hashimoto M, Imoto S, Yamasaki K, Otagiri M.

J Pharm Sci. 2019 Dec;108(12):3911-3916. doi: 10.1016/j.xphs.2019.09.003. Epub 2019 Sep 11.

PMID:
31520646
10.

Enhanced dissolution and oral bioavailability of praziquantel by emulsification with human serum albumin followed by spray drying.

Yamasaki K, Taguchi K, Nishi K, Otagiri M, Seo H.

Eur J Pharm Sci. 2019 Nov 1;139:105064. doi: 10.1016/j.ejps.2019.105064. Epub 2019 Sep 3.

PMID:
31491499
11.

Preparation, Characterization, and in Vitro/in Vivo Evaluation of Paclitaxel-Bound Albumin-Encapsulated Liposomes for the Treatment of Pancreatic Cancer.

Okamoto Y, Taguchi K, Sakuragi M, Imoto S, Yamasaki K, Otagiri M.

ACS Omega. 2019 May 17;4(5):8693-8700. doi: 10.1021/acsomega.9b00537. eCollection 2019 May 31.

12.

α1-Acid Glycoprotein Has the Potential to Serve as a Biomimetic Drug Delivery Carrier for Anticancer Agents.

Matsusaka K, Ishima Y, Maeda H, Kinoshita R, Ichimizu S, Taguchi K, Giam Chuang VT, Nishi K, Yamasaki K, Otagiri M, Watanabe H, Maruyama T.

J Pharm Sci. 2019 Nov;108(11):3592-3598. doi: 10.1016/j.xphs.2019.07.002. Epub 2019 Jul 6.

PMID:
31288036
13.

Cell-penetrating mechanism of intracellular targeting albumin: Contribution of macropinocytosis induction and endosomal escape.

Ichimizu S, Watanabe H, Maeda H, Hamasaki K, Ikegami K, Chuang VTG, Kinoshita R, Nishida K, Shimizu T, Ishima Y, Ishida T, Seki T, Katsuki H, Futaki S, Otagiri M, Maruyama T.

J Control Release. 2019 Jun 28;304:156-163. doi: 10.1016/j.jconrel.2019.05.015. Epub 2019 May 10.

PMID:
31082432
14.

Distribution of Polysulfide in Human Biological Fluids and Their Association with Amylase and Sperm Activities.

Ikeda M, Ishima Y, Chuang VTG, Sakai M, Osafune H, Ando H, Shimizu T, Okuhira K, Watanabe H, Maruyama T, Otagiri M, Akaike T, Ishida T.

Molecules. 2019 Apr 30;24(9). pii: E1689. doi: 10.3390/molecules24091689.

15.

Investigation of anti-tumor effect of doxorubicin-loaded human serum albumin nanoparticles prepared by a desolvation technique.

Kimura K, Yamasaki K, Nishi K, Taguchi K, Otagiri M.

Cancer Chemother Pharmacol. 2019 Jun;83(6):1113-1120. doi: 10.1007/s00280-019-03832-3. Epub 2019 Apr 10.

PMID:
30972458
16.

Design and Evaluation of An Extended-Release Olmesartan Tablet Using Chitosan/Cyclodextrin Composites.

Anraku M, Tabuchi R, Goto M, Iohara D, Mizukai Y, Maezaki Y, Michihara A, Kadowaki D, Otagiri M, Hirayama F.

Pharmaceutics. 2019 Feb 15;11(2). pii: E82. doi: 10.3390/pharmaceutics11020082.

17.

Further Evidence Regarding the Important Role of Chlorine Atoms of Aripiprazole on Binding to the Site II Area of Human Albumin.

Sakurama K, Nishi K, Imoto S, Hashimoto M, Komatsu T, Morita Y, Taguchi K, Otagiri M, Yamasaki K.

J Pharm Sci. 2019 May;108(5):1890-1895. doi: 10.1016/j.xphs.2018.11.045. Epub 2018 Dec 8.

PMID:
30537471
18.

Glutamine Deprivation Enhances Acetyl-CoA Carboxylase Inhibitor-induced Death of Human Pancreatic Cancer Cells.

Nishi K, Suzuki M, Yamamoto N, Matsumoto A, Iwase Y, Yamasaki K, Otagiri M, Yumita N.

Anticancer Res. 2018 Dec;38(12):6683-6689. doi: 10.21873/anticanres.13036.

PMID:
30504377
19.

Use of hemoglobin for delivering exogenous carbon monoxide in medicinal applications.

Taguchi K, Maruyama T, Otagiri M.

Curr Med Chem. 2018 Nov 13. doi: 10.2174/0929867325666181113122340. [Epub ahead of print]

PMID:
30421669
20.

Analysis of the Binding of Aripiprazole to Human Serum Albumin: The Importance of a Chloro-Group in the Chemical Structure.

Sakurama K, Kawai A, Tuan Giam Chuang V, Kanamori Y, Osa M, Taguchi K, Seo H, Maruyama T, Imoto S, Yamasaki K, Otagiri M.

ACS Omega. 2018 Oct 31;3(10):13790-13797. doi: 10.1021/acsomega.8b02057. Epub 2018 Oct 22.

21.

Antioxidant activities of chitosans and its derivatives in in vitro and in vivo studies.

Anraku M, Gebicki JM, Iohara D, Tomida H, Uekama K, Maruyama T, Hirayama F, Otagiri M.

Carbohydr Polym. 2018 Nov 1;199:141-149. doi: 10.1016/j.carbpol.2018.07.016. Epub 2018 Jul 7. Review.

PMID:
30143114
22.

Benzbromarone Attenuates Oxidative Stress in Angiotensin II- and Salt-Induced Hypertensive Model Rats.

Muraya N, Kadowaki D, Miyamura S, Kitamura K, Uchimura K, Narita Y, Miyamoto Y, Chuang VTG, Taguchi K, Maruyama T, Otagiri M, Hirata S.

Oxid Med Cell Longev. 2018 Jun 5;2018:7635274. doi: 10.1155/2018/7635274. eCollection 2018.

23.

Pharmacokinetic properties of a novel inosine analog, 4'-cyano-2'-deoxyinosine, after oral administration in rats.

Hashimoto M, Taguchi K, Ishiguro T, Kohgo S, Imoto S, Yamasaki K, Mitsuya H, Otagiri M.

PLoS One. 2018 Jun 6;13(6):e0198636. doi: 10.1371/journal.pone.0198636. eCollection 2018.

24.

Metal-catalyzed oxidation of human serum albumin does not alter the interactive binding to the two principal drug binding sites.

Yamasaki K, Nishi K, Anraku M, Taguchi K, Maruyama T, Otagiri M.

Biochem Biophys Rep. 2018 May 11;14:155-160. doi: 10.1016/j.bbrep.2018.05.002. eCollection 2018 Jul.

25.

Biomimetic carbon monoxide delivery based on hemoglobin vesicles ameliorates acute pancreatitis in mice via the regulation of macrophage and neutrophil activity.

Taguchi K, Nagao S, Maeda H, Yanagisawa H, Sakai H, Yamasaki K, Wakayama T, Watanabe H, Otagiri M, Maruyama T.

Drug Deliv. 2018 Nov;25(1):1266-1274. doi: 10.1080/10717544.2018.1477860.

26.

Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actions.

Minayoshi Y, Maeda H, Yanagisawa H, Hamasaki K, Mizuta Y, Nishida K, Kinoshita R, Enoki Y, Imafuku T, Chuang VTG, Koga T, Fujiwara Y, Takeya M, Sonoda K, Wakayama T, Taguchi K, Ishima Y, Ishida T, Iwakiri Y, Tanaka M, Sasaki Y, Watanabe H, Otagiri M, Maruyama T.

Drug Deliv. 2018 Nov;25(1):1067-1077. doi: 10.1080/10717544.2018.1464083.

27.

Preparation and in Vitro Analysis of Human Serum Albumin Nanoparticles Loaded with Anthracycline Derivatives.

Kimura K, Yamasaki K, Nakamura H, Haratake M, Taguchi K, Otagiri M.

Chem Pharm Bull (Tokyo). 2018;66(4):382-390. doi: 10.1248/cpb.c17-00838.

28.

Design and tuning of a cell-penetrating albumin derivative as a versatile nanovehicle for intracellular drug delivery.

Ichimizu S, Watanabe H, Maeda H, Hamasaki K, Nakamura Y, Chuang VTG, Kinoshita R, Nishida K, Tanaka R, Enoki Y, Ishima Y, Kuniyasu A, Kobashigawa Y, Morioka H, Futaki S, Otagiri M, Maruyama T.

J Control Release. 2018 May 10;277:23-34. doi: 10.1016/j.jconrel.2018.02.037. Epub 2018 Mar 10.

PMID:
29530390
29.

Pharmacokinetics studies of 4'-cyano-2'-deoxyguanosine, a potent inhibitor of the hepatitis B virus, in rats.

Hashimoto M, Taguchi K, Ishiguro T, Kohgo S, Imoto S, Yamasaki K, Mitsuya H, Otagiri M.

J Pharm Pharmacol. 2018 Jun;70(6):723-731. doi: 10.1111/jphp.12897. Epub 2018 Mar 12.

PMID:
29528116
30.

Crystal structure analysis of human serum albumin complexed with sodium 4-phenylbutyrate.

Kawai A, Yamasaki K, Enokida T, Miyamoto S, Otagiri M.

Biochem Biophys Rep. 2018 Jan 28;13:78-82. doi: 10.1016/j.bbrep.2018.01.006. eCollection 2018 Mar.

31.

Trp residue at subsite - 5 plays a critical role in the substrate binding of two protistan GH26 β-mannanases from a termite hindgut.

Hsu Y, Koizumi H, Otagiri M, Moriya S, Arioka M.

Appl Microbiol Biotechnol. 2018 Feb;102(4):1737-1747. doi: 10.1007/s00253-017-8726-2. Epub 2018 Jan 5.

PMID:
29305697
32.

Thioredoxin-albumin fusion protein prevents copper enhanced zinc-induced neurotoxicity via its antioxidative activity.

Tanaka KI, Shimoda M, Chuang VTG, Nishida K, Kawahara M, Ishida T, Otagiri M, Maruyama T, Ishima Y.

Int J Pharm. 2018 Jan 15;535(1-2):140-147. doi: 10.1016/j.ijpharm.2017.11.012. Epub 2017 Nov 6.

PMID:
29122608
33.

Dual Therapeutic Effects of an Albumin-Based Nitric Oxide Donor on 2 Experimental Models of Chronic Kidney Disease.

Oshiro S, Ishima Y, Maeda H, Honda N, Bi J, Kinoshita R, Ikeda M, Iwao Y, Imafuku T, Nishida K, Miyamura S, Watanabe H, Otagiri M, Maruyama T.

J Pharm Sci. 2018 Mar;107(3):848-855. doi: 10.1016/j.xphs.2017.10.023. Epub 2017 Oct 24.

PMID:
29074377
34.

A novel S-sulfhydrated human serum albumin preparation suppresses melanin synthesis.

Ikeda M, Ishima Y, Kinoshita R, Chuang VTG, Tasaka N, Matsuo N, Watanabe H, Shimizu T, Ishida T, Otagiri M, Maruyama T.

Redox Biol. 2018 Apr;14:354-360. doi: 10.1016/j.redox.2017.10.007. Epub 2017 Oct 11.

35.

Recombinant Human Serum Albumin Containing 3 Copies of Domain I, Has Significant in Vitro Antioxidative Capacity Compared to the Wild-Type.

Matsushita S, Nishi K, Iwao Y, Ishima Y, Watanabe H, Taguchi K, Yamasaki K, Maruyama T, Otagiri M.

Biol Pharm Bull. 2017;40(10):1813-1817. doi: 10.1248/bpb.b17-00528.

36.

Parathyroid hormone contributes to the down-regulation of cytochrome P450 3A through the cAMP/PI3K/PKC/PKA/NF-κB signaling pathway in secondary hyperparathyroidism.

Watanabe H, Sugimoto R, Ikegami K, Enoki Y, Imafuku T, Fujimura R, Bi J, Nishida K, Sakaguchi Y, Murata M, Maeda H, Hirata K, Jingami S, Ishima Y, Tanaka M, Matsushita K, Komaba H, Fukagawa M, Otagiri M, Maruyama T.

Biochem Pharmacol. 2017 Dec 1;145:192-201. doi: 10.1016/j.bcp.2017.08.016. Epub 2017 Aug 24.

PMID:
28843775
37.

Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core.

Okamoto Y, Taguchi K, Yamasaki K, Sakuragi M, Kuroda S, Otagiri M.

J Pharm Sci. 2018 Jan;107(1):436-445. doi: 10.1016/j.xphs.2017.08.003. Epub 2017 Aug 18.

PMID:
28826882
38.

Surface-deacetylated chitin nanofibers reinforced with a sulfobutyl ether β-cyclodextrin gel loaded with prednisolone as potential therapy for inflammatory bowel disease.

Tabuchi R, Anraku M, Iohara D, Ishiguro T, Ifuku S, Nagae T, Uekama K, Okazaki S, Takeshita K, Otagiri M, Hirayama F.

Carbohydr Polym. 2017 Oct 15;174:1087-1094. doi: 10.1016/j.carbpol.2017.07.028. Epub 2017 Jul 13.

PMID:
28821031
39.

Novel squalene-producing thraustochytrids found in mangrove water.

Otagiri M, Khalid A, Moriya S, Osada H, Takahashi S.

Biosci Biotechnol Biochem. 2017 Oct;81(10):2034-2037. doi: 10.1080/09168451.2017.1359485. Epub 2017 Aug 10.

PMID:
28795620
40.

A Comparison of the Phosphorus Content in Prescription Medications for Hemodialysis Patients in Japan.

Shimoishi K, Anraku M, Uto A, Iohara D, Hirayama F, Kadowaki D, Zingami S, Maruyama T, Otagiri M.

Yakugaku Zasshi. 2017;137(7):903-908. doi: 10.1248/yakushi.17-00006.

41.

Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin.

Yamasaki K, Hyodo S, Taguchi K, Nishi K, Yamaotsu N, Hirono S, Chuang VTG, Seo H, Maruyama T, Otagiri M.

PLoS One. 2017 Jun 29;12(6):e0180404. doi: 10.1371/journal.pone.0180404. eCollection 2017.

42.

Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer.

Kinoshita R, Ishima Y, Chuang VTG, Nakamura H, Fang J, Watanabe H, Shimizu T, Okuhira K, Ishida T, Maeda H, Otagiri M, Maruyama T.

Biomaterials. 2017 Sep;140:162-169. doi: 10.1016/j.biomaterials.2017.06.021. Epub 2017 Jun 22.

PMID:
28651144
43.

Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction.

Enoki Y, Watanabe H, Arake R, Fujimura R, Ishiodori K, Imafuku T, Nishida K, Sugimoto R, Nagao S, Miyamura S, Ishima Y, Tanaka M, Matsushita K, Komaba H, Fukagawa M, Otagiri M, Maruyama T.

J Cachexia Sarcopenia Muscle. 2017 Oct;8(5):735-747. doi: 10.1002/jcsm.12202. Epub 2017 Jun 12.

44.

Comparison of the pharmacological and biological properties of HPMA copolymer-pirarubicin conjugates: A single-chain copolymer conjugate and its biodegradable tandem-diblock copolymer conjugate.

Etrych T, Tsukigawa K, Nakamura H, Chytil P, Fang J, Ulbrich K, Otagiri M, Maeda H.

Eur J Pharm Sci. 2017 Aug 30;106:10-19. doi: 10.1016/j.ejps.2017.05.031. Epub 2017 May 18.

PMID:
28528285
45.

Crystallographic analysis of the ternary complex of octanoate and N-acetyl-l-methionine with human serum albumin reveals the mode of their stabilizing interactions.

Kawai A, Chuang VTG, Kouno Y, Yamasaki K, Miyamoto S, Anraku M, Otagiri M.

Biochim Biophys Acta Proteins Proteom. 2017 Aug;1865(8):979-984. doi: 10.1016/j.bbapap.2017.04.004. Epub 2017 May 1.

PMID:
28473296
46.

Species Differences in the Binding of Sodium 4-Phenylbutyrate to Serum Albumin.

Yamasaki K, Enokida T, Taguchi K, Miyamura S, Kawai A, Miyamoto S, Maruyama T, Seo H, Otagiri M.

J Pharm Sci. 2017 Sep;106(9):2860-2867. doi: 10.1016/j.xphs.2017.04.025. Epub 2017 Apr 26.

PMID:
28456727
47.

The Use of Hemoglobin Vesicles for Delivering Medicinal Gas for the Treatment of Intractable Disorders.

Taguchi K, Yamasaki K, Sakai H, Maruyama T, Otagiri M.

J Pharm Sci. 2017 Sep;106(9):2392-2400. doi: 10.1016/j.xphs.2017.04.006. Epub 2017 Apr 13. Review.

PMID:
28414143
48.

Apoptosis induction of poly-S-nitrosated human serum albumin in resistant solid tumor under hypoxia can be restored by phosphodiesterase 5 inhibition.

Ikeda M, Ishima Y, Chuang VTG, Ikeda T, Kinoshita R, Watanabe H, Ishida T, Otagiri M, Maruyama T.

Nitric Oxide. 2017 Sep 30;69:28-34. doi: 10.1016/j.niox.2017.04.005. Epub 2017 Apr 13.

PMID:
28414103
49.

Quantitative determination of polysulfide in albumins, plasma proteins and biological fluid samples using a novel combined assays approach.

Ikeda M, Ishima Y, Shibata A, Chuang VTG, Sawa T, Ihara H, Watanabe H, Xian M, Ouchi Y, Shimizu T, Ando H, Ukawa M, Ishida T, Akaike T, Otagiri M, Maruyama T.

Anal Chim Acta. 2017 May 29;969:18-25. doi: 10.1016/j.aca.2017.03.027. Epub 2017 Mar 22.

PMID:
28411626
50.

Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen Carriers.

Taguchi K, Yamasaki K, Maruyama T, Otagiri M.

J Funct Biomater. 2017 Mar 18;8(1). pii: E11. doi: 10.3390/jfb8010011. Review.

Supplemental Content

Loading ...
Support Center